Knight Therapeutics Inc T.GUD

Knight Therapeutics Inc. Receives Consensus "Buy" Rating

[MrMugsy]

Knight Therapeutics Inc. (TSE:GUD) has been assigned a consensus recommendation of "Buy" from the six research firms that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last year is C$7.65.

https://www.marketbeat.com/instant-alerts/tse-gud-consensus-analyst-rating-2021-12/

[NobleFr]

Anyone who looks at this stock, including analysts, will see that 600m market cap for a company with 300m cash and 40m and growing annualized free cash flow is a buy 

[Chianchin]

Most of the litle "not $300M" available cash is now is being waisted /used in the overpriced buy back to keep this stock not crashing below $5 thus trigering a major sell out by institutional investors and MNGT fired. Just a mater of time. Once $5 is breached $2.99 

[gudisgood]

The cash flow from operations (roughly $40m so far this year) is growing impressively, regardless of what happens in Q4. It's likely to continue growing at a nice clip for the next few years just because of our existing portfolio of drugs. It was good to hear from Amal that "the team is quite active and deal flow continues to be quite strong across the territory." Hopefully we'

[Chianchin]

GUDisBAD you have posted a bunch of nonsense.You are clearly jusst another clone of Mr Mugsy-nod broken crackpot peices